Meta-analysis and systematic review of prognostic significance of Glypican-3 in patients with hepatitis B-related hepatocellular carcinoma
- PMID: 31179356
- PMCID: PMC6531550
- DOI: 10.1007/s13337-019-00517-6
Meta-analysis and systematic review of prognostic significance of Glypican-3 in patients with hepatitis B-related hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) is a common malignant cancer and the second cause of cancer-related death worldwide. Glypican-3 (GPC3) is established as an important prognostic factor for HCC but the results are still controversial. Moreover, its utility as an immunohistochemical marker for HCC is not conclusive. Herein we aimed to find the prognostic significance of GPC3 in HCC patients. The PubMed, Web of Science, EMBASE, SCOPUS and Cochrane library databases were searched and eligible studies based on the GPC3 expression and survival outcome of HCC (odds ratios or hazard ratios) included in the current meta-analysis. The STATA 12.0 and RevMan 5.3 software were used for statistical evaluations. 17 articles contained 2618 patients, were included in the recent meta-analysis. Our findings revealed a significant association between tumor stage, higher tumor grade, presence of vascular invasion, shorter overall survival, shorter disease-free survival and high expression of GPC3. The subgroup analyses based on sample size, cutoffs and follow-up period were also conducted to examine the association between GPC3 and OS and also to increase the homogeneity of study. Current study found a significant association between GPC3 expression and poor prognosis of HCC and specially related to the HCC invasion and progression. It was recommended to design more prospective studies based on the relationship between GPC3 and HCC to confirm our results.
Keywords: GPC3; HCC; Meta-analysis.
Conflict of interest statement
Conflict of interestThe authors declare that they have no conflict of interest.
Figures



Similar articles
-
Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis.Medicine (Baltimore). 2018 Jan;97(4):e9702. doi: 10.1097/MD.0000000000009702. Medicine (Baltimore). 2018. PMID: 29369198 Free PMC article. Review.
-
Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.World J Gastroenterol. 2014 May 28;20(20):6336-44. doi: 10.3748/wjg.v20.i20.6336. World J Gastroenterol. 2014. PMID: 24876756 Free PMC article.
-
Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis.BMC Cancer. 2014 Feb 18;14:104. doi: 10.1186/1471-2407-14-104. BMC Cancer. 2014. PMID: 24548704 Free PMC article.
-
Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis.Medicine (Baltimore). 2018 Jun;97(24):e11130. doi: 10.1097/MD.0000000000011130. Medicine (Baltimore). 2018. PMID: 29901640 Free PMC article. Review.
-
Diagnostic and Prognostic Value of Isolated and Combined MCM3 and Glypican-3 Expression in Hepatocellular Carcinoma: A Novel Immunosubtyping Prognostic Model.Appl Immunohistochem Mol Morphol. 2022 Nov-Dec 01;30(10):694-702. doi: 10.1097/PAI.0000000000001080. Epub 2022 Oct 24. Appl Immunohistochem Mol Morphol. 2022. PMID: 36350065
Cited by
-
Identification of HLA-A2 restricted epitopes of glypican-3 and induction of CTL responses in HLA-A2 transgenic mice.Cancer Immunol Immunother. 2022 Jul;71(7):1569-1582. doi: 10.1007/s00262-021-03096-y. Epub 2021 Nov 1. Cancer Immunol Immunother. 2022. PMID: 34724090 Free PMC article.
-
HEPPAR1 and PIWIL2 as Panel Markers for Hepatocellular Carcinoma.Asian Pac J Cancer Prev. 2024 Jun 1;25(6):2123-2131. doi: 10.31557/APJCP.2024.25.6.2123. Asian Pac J Cancer Prev. 2024. PMID: 38918675 Free PMC article.
-
The role of glypican-3 in hepatocellular carcinoma: Insights into diagnosis and therapeutic potential.Eur J Med Res. 2024 Oct 5;29(1):490. doi: 10.1186/s40001-024-02073-2. Eur J Med Res. 2024. PMID: 39369212 Free PMC article. Review.
-
Hepatocyte paraffin 1 and arginase-1 are effective panel of markers in HBV-related HCC diagnosis in fine-needle aspiration specimens.BMC Res Notes. 2020 Aug 20;13(1):388. doi: 10.1186/s13104-020-05230-y. BMC Res Notes. 2020. PMID: 32854754 Free PMC article.
-
Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma.BMC Cancer. 2021 Apr 26;21(1):462. doi: 10.1186/s12885-021-08104-z. BMC Cancer. 2021. PMID: 33902495 Free PMC article.
References
-
- Begg CB. A comparison of methods to detect publication bias in meta-analysis by P. Macaskill, S. D. Walter and L. Irwig, Stat. Med. 2001;20:641–654. Stat Med. 2002;21(12):1803; author reply 4. - PubMed
LinkOut - more resources
Full Text Sources